Tim Demuth
Sandoz, Germany
Biography
Tim Demuth, MD is a Clinical Development Unit Head at Sandoz Biopharma responsible for clinical strategy, and execution of biosimilar development programs. He has extensive experience in early and late stage drug development across multiple therapeutic areas including immunology, hematology and oncology. He has great passion for innovative approaches to drug development with the aim to improve patient access to medicines.
Abstract
Abstract : Development of Etanercept biosimilar Erelzi